Paschal A. Oude Weernink

1.9k total citations
27 papers, 1.6k citations indexed

About

Paschal A. Oude Weernink is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Paschal A. Oude Weernink has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Paschal A. Oude Weernink's work include Protein Kinase Regulation and GTPase Signaling (18 papers), Receptor Mechanisms and Signaling (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Paschal A. Oude Weernink is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (18 papers), Receptor Mechanisms and Signaling (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). Paschal A. Oude Weernink collaborates with scholars based in Germany, Netherlands and Japan. Paschal A. Oude Weernink's co-authors include Martina Schmidt, Karl H. Jakobs, Gert Rijksen, Sandrine Evellin, F. vom Dorp, Jon W. Lomasney, Maider López de Jesús, Holger Rehmann, Matthias B. Stope and Matthias Voß and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Nature Cell Biology.

In The Last Decade

Paschal A. Oude Weernink

27 papers receiving 1.6k citations

Peers

Countries citing papers authored by Paschal A. Oude Weernink

Since Specialization

Citations

This map shows the geographic impact of Paschal A. Oude Weernink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paschal A. Oude Weernink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paschal A. Oude Weernink more than expected).

Fields of papers citing papers by Paschal A. Oude Weernink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paschal A. Oude Weernink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paschal A. Oude Weernink. The network helps show where Paschal A. Oude Weernink may publish in the future.

Co-authorship network of co-authors of Paschal A. Oude Weernink

This figure shows the co-authorship network connecting the top 25 collaborators of Paschal A. Oude Weernink. A scholar is included among the top collaborators of Paschal A. Oude Weernink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paschal A. Oude Weernink. Paschal A. Oude Weernink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B cell receptor-induced growth arrest and apoptosis in WEHI-231 immature B lymphoma cells involve cyclic AMP and Epac proteins 2009 ·Cellular Signalling ·Maria Grandoch, Maider López de Jesús, Paschal A. Oude Weernink, Artur‐Aron Weber, Karl H. Jakobs, Martina Schmidt	25
2	Direct stimulation of receptor‐controlled phospholipase D1 by phospho‐cofilin 2007 ·The EMBO Journal ·Li Han, Matthias B. Stope, Maider López de Jesús, Paschal A. Oude Weernink, (unknown), Thomas Wieland, Dieter Rosskopf, Kensaku Mizuno, Karl H. Jakobs, Martina Schmidt	85
3	Epac and the cardiovascular system 2007 ·Current Opinion in Pharmacology ·Martina Schmidt, Carsten Sand, K H Jakobs, Martin C. Michel, Paschal A. Oude Weernink	41
4	Phospholipase D signaling: orchestration by PIP2 and small GTPases 2007 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Paschal A. Oude Weernink, Maider López de Jesús, Martina Schmidt	87
5	Dynamic phospholipid signaling by G protein-coupled receptors 2006 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Paschal A. Oude Weernink, Han Li, Karl H. Jakobs, Martina Schmidt	80
6	Cyclic AMP-dependent and Epac-mediated Activation of R-Ras by G Protein-coupled Receptors Leads to Phospholipase D Stimulation 2006 ·Journal of Biological Chemistry ·Maider López de Jesús, Matthias B. Stope, Paschal A. Oude Weernink, (unknown), (unknown), (unknown), Christian Rimmbach, Dieter Rosskopf, Martin C. Michel, Karl H. Jakobs, Martina Schmidt	63
7	Regulation and cellular roles of phosphoinositide 5-kinases 2004 ·European Journal of Pharmacology ·Paschal A. Oude Weernink, Martina Schmidt, Karl H. Jakobs	114
8	Epac- and Ca2+-controlled Activation of Ras and Extracellular Signal-regulated Kinases by Gs-coupled Receptors 2004 ·Journal of Biological Chemistry ·(unknown), Matthias B. Stope, (unknown), (unknown), (unknown), F. vom Dorp, (unknown), Paschal A. Oude Weernink, Sandrine Evellin, Karl H. Jakobs, Martina Schmidt	92
9	Activation of Type I Phosphatidylinositol 4-Phosphate 5-Kinase Isoforms by the Rho GTPases, RhoA, Rac1, and Cdc42 2004 ·Journal of Biological Chemistry ·Paschal A. Oude Weernink, (unknown), (unknown), (unknown), Hisamitsu Ishihara, Martina Schmidt, Karl H. Jakobs	147
10	A new phospholipase-C–calcium signalling pathway mediated by cyclic AMP and a Rap GTPase 2001 ·Nature Cell Biology ·Martina Schmidt, Sandrine Evellin, Paschal A. Oude Weernink, F. vom Dorp, Holger Rehmann, Jon W. Lomasney, Karl H. Jakobs	287
11	Stimulation of Phosphatidylinositol-4-phosphate 5-Kinase by Rho-Kinase 2000 ·Journal of Biological Chemistry ·Paschal A. Oude Weernink, (unknown), Yuanjian Guo, (unknown), Mutsuki Amano, Kozo Kaibuchi, (unknown), Matthias Voß, Martina Schmidt, Georg W. Mayr, Karl H. Jakobs	89
12	Control of cellular phosphatidylinositol 4,5‐bisphosphate levels by adhesion signals and Rho GTPases in NIH 3T3 fibroblasts 2000 ·European Journal of Biochemistry ·Paschal A. Oude Weernink, Yuanjian Guo, Chunyi Zhang, Martina Schmidt, Christoph von Eichel‐Streiber, Karl H. Jakobs	26
13	A Role for Rho-kinase in Rho-controlled Phospholipase D Stimulation by the m3 Muscarinic Acetylcholine Receptor 1999 ·Journal of Biological Chemistry ·Martina Schmidt, Matthias Voß, Paschal A. Oude Weernink, (unknown), Mutsuki Amano, Kozo Kaibuchi, Karl H. Jakobs	77
14	Epidermal growth factor-induced activation and translocation of c-Src to the cytoskeleton depends on the actin binding domain of the EGF-receptor 1997 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Marcel A. G. van der Heyden, Paschal A. Oude Weernink, Brigitte A. van Oirschot, Paul M.P. van Bergen en Henegouwen, Johannes Boonstra, Gert Rijksen	14
15	Determination of specific protein kinase activities using phosphorus-33 1996 ·Journal of Biochemical and Biophysical Methods ·Paschal A. Oude Weernink, Gert Rijksen	6
16	Activation and Translocation of c-Src to the Cytoskeleton by Both Platelet-derived Growth Factor and Epidermal Growth Factor 1995 ·Journal of Biological Chemistry ·Paschal A. Oude Weernink, Gert Rijksen	78
17	Functional interaction between the epidermal growth factor receptor and c‐Src kinase activity 1994 ·FEBS Letters ·Paschal A. Oude Weernink, (unknown), (unknown), (unknown), G.E.J. Staal, Gert Rijksen	32
18	Phosphorylation of pyruvate kinase type K is restricted to the dimeric form 1992 ·Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology ·Paschal A. Oude Weernink, Gert Rijksen, Ellen M. Mascini, (unknown)	17
19	Phosphorylation of Pyruvate Kinase and Glycolytic Metabolism in Three Human Glioma Cell Lines 1991 ·Tumor Biology ·Paschal A. Oude Weernink, Gert Rijksen, G.E.J. Staal	10
20	Production of a specific antibody against pyruvate kinase type M2 using a synthetic peptide 1988 ·FEBS Letters ·Paschal A. Oude Weernink, Gert Rijksen, G.E.J. Staal	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact